Subclassification and outcome prediction of patients with muscle invasive urothelial carcinoma (MIUC) treated by radical cystectomy (RC) with a NanoString based molecular screening

MLA

Annette Steidler, et al. “Subclassification and Outcome Prediction of Patients with Muscle Invasive Urothelial Carcinoma (MIUC) Treated by Radical Cystectomy (RC) with a NanoString Based Molecular Screening.” Journal of Clinical Oncology, vol. 34, May 2016, p. 4525. EBSCOhost, https://doi.org/10.1200/jco.2016.34.15_suppl.4525.

APA

Annette Steidler, Philipp Erben, Cleo-Aron Weis, Thomas Stefan Worst, Arndt Hartmann, Christian Bolenz, & Sebastien Rinaldetti. (2016). Subclassification and outcome prediction of patients with muscle invasive urothelial carcinoma (MIUC) treated by radical cystectomy (RC) with a NanoString based molecular screening. Journal of Clinical Oncology, 34, 4525. https://doi.org/10.1200/jco.2016.34.15_suppl.4525

Chicago

Annette Steidler, Philipp Erben, Cleo-Aron Weis, Thomas Stefan Worst, Arndt Hartmann, Christian Bolenz, and Sebastien Rinaldetti. 2016. “Subclassification and Outcome Prediction of Patients with Muscle Invasive Urothelial Carcinoma (MIUC) Treated by Radical Cystectomy (RC) with a NanoString Based Molecular Screening.” Journal of Clinical Oncology 34 (May): 4525. doi:10.1200/jco.2016.34.15_suppl.4525.